Revvity
Sara Elizabeth Smith is an experienced professional in research and development, currently serving as Associate Director at Revvity since May 2023, where leadership is provided in the development of biochemical assays and laboratory tests, including regulatory submissions. Previously, roles at PerkinElmer Genomics encompassed Senior Manager and Manager of Research Applications and Biochemical Diagnostics, with responsibilities focused on developing mass spectrometry assays for newborn screening. Sara's earlier experience includes a position as Senior Scientist at MilliporeSigma, where novel sample preparation techniques were developed, along with several teaching roles at the University of Pittsburgh and Penn State University. Sara holds a PhD in Analytical Chemistry, a Master of Professional Studies in Forensic Science, and a Bachelor of Science in Chemistry.
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com